Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 20 Issue 7, July 2002

Nuclear transplantation in process. A bovine oocyte is held by a glass pipette (left),while a glass needle (right) is used to remove the maternal nucleus. A polar body (top) is located just underneath the zona pellucida (the thick envelope surrounding the ovum). Stained with bisbenzimide (Hoeschst 33342; Sigma) dye and visualized under a fluorescence microscope. On page 689, Lanza et al. report the successful transplantation of cloned cells into a steer. Picture courtesy Advanced Cell Technology.

Editorial

Top of page ⤴

Business and Regulatory News

Top of page ⤴

Commentary

Top of page ⤴

Fools Corner

Top of page ⤴

Book Review

Top of page ⤴

Correspondence

Top of page ⤴

Feature

  • Therapeutic cancer vaccines offer hope for patients for whom traditional treatments have failed, but various obstacles may impede the launch of these new agents.

    • Janice M. Reichert
    • Cherie Paquette
    Feature
Top of page ⤴

News & Views

  • Therapeutic cloning promises to provide genetically matched replacement tissue, but non-self mitochondrial proteins derived from the recipient oocyte could render cloned tissue immunogenic. A new study examines this issue.

    • Hugh Auchincloss
    • Joseph V. Bonventre
    News & Views
  • Two reports on whole-genome shuffling demonstrate the application of combinatorial methods for phenotypic improvement in bacteria.

    • Gregory Stephanopoulos
    News & Views
  • Programmable ribozymes that can attach non-natural amino acids to specific tRNAs may expand the range of amino acids available for protein engineering.

    • Koji Tamura
    • Paul Schimmel
    News & Views
  • Reporter ribozymes that allow monitoring of protein–nucleic acid and protein–protein interactions facilitate rapid identification of inhibitors for use in drug discovery.

    • Larry Gold
    News & Views
Top of page ⤴

News in Brief

Top of page ⤴

Review Article

Top of page ⤴

Article

Top of page ⤴

Technical Report

Top of page ⤴

Patents

Top of page ⤴

People

Top of page ⤴

New on the Market

Top of page ⤴

Careers and Recruitment

  • Every year, thousands of researchers head for the US National Institutes of Health. But what draws them there?

    • Karen Kreeger
    Careers and Recruitment
Top of page ⤴

Search

Quick links